Role of trimetazidine in carbon tetrachloride induced liver damage in rats
Keywords:Trimetazidine, Hepatoprotective, Prophylactic
Background: Hepatotoxicity by chemicals and drugs is a common clinical problem. Presently very few drugs are showing effectiveness in prevention and treatment of hepatic damage. So in this study, we evaluated the role of trimetazidine in carbon tetrachloride (CCl4) induced liver damage in rats. Objective of current study is to evaluate effects of prophylactic trimetazidine against carbon tetrachloride induced liver damage in rats.
Methods: Liver damage was induced in 30 albino rats by CCl4 (0.5 ml/kg, i.p.) once daily for 7 days. Extent of damage was studied by assessing biochemical parameters (SGOT, SGPT, ALP, proteins and bilirubin). These biochemical observations were supplemented by pentobarbitone Sleeping Time and Histological Examination of liver. The effect of co-administration of trimetazidine (doses 5 and 10 mg/kg p. o.) on the above parameters was investigated. Liv.52® was used as Positive Control. Data was analyzed by one way ANOVA, followed by Dunnett's test.
Results: Trimetazidine significantly prevented CCl4 induced elevation of serum SGOT, SGPT, ALP and bilirubin (total and direct), and reduction in protein level. Pentobarbitone sleeping time and histological examination of the liver showed consistent results. The results were comparable to that of Liv.52®.
Conclusions: Trimetazidine, when administered prophylactically, shows hepatoprotective effect against CCl4 induced liver damage.
Sheila Sherlock, James Dooley. Drug and the liver. In: Diseases of the liver and biliary system. 11th edition. Paris: Blackwell Publishing; 2002: 335.
Christine K, Cassel. Geriatric medicine: an evidence-based approach. 4th edition. New York: Springer publication; 2003: 844.
Anthony S. Fauci, Eugene Braunwald, Dennis Kasper, Tinsley Randolph Harrison, Dan L. Longo. Harrison’s principles of internal medicine. 17th edition. New York: McGraw-Hill Medical Publication; 2008: 264-8.
Manouchehr Khoshbaten, Akbar Aliasgarzadeh, et al. N-Acetylcysteine Improves Liver Function in Patients with Non-Alcoholic Fatty Liver Disease. Hepatitis Monthly. 2010;10(1):12-16.
Charles S Lieber. S-Adenosyl-L-methionine: its role in the treatment of liverdisorders. Am J Clin Nutr. 2002;76(suppl):1183S–7S.
Parola M, Leonarduzzi G et al. Vitamin E dietary supplementation protects against carbon tetrachloride-induced chronic liver damage and cirrhosis. Hepatology. 1992Oct;16(4):1014-21.
Sean C. Sweatman, Editor. Martindale: The Complete Drug Reference. 34th edition. London: Pharmaceutical Press; 2005: 1018.
Tripathi KD. Essentials of Medical pharmacology. 6th edition. New Delhi: Jaypee publication; 2008: 535.
Ghosh MN. Fundamentals of Experimental Pharmacology. 4th edition. Hilton and company; 2008: 178-179.
Maheshwari M. Uma, Rao PGM. Antihepatotoxic effect of grape seed oil in rat. Indian journal of Pharmacology. 2005June;37(3);179-82.
Kolhapure, S.A., Mitra, S.K. Meta-analysis of 50 Phase III clinical trials in evaluation of efficacy and safety of Liv.52 in infective hepatitis. Medicine Update. 2004;12(2)51-61.
Shivani Pandey, Gujrati VR, Shanker K, Singh N and Dhawan KN. Hepatoprotective effect of Liv.52® Against CCl4-induced Lipid Peroxidation in Liver of Rats. Indian Journal of Experimental Biology. 1994September;32:674-5.
Sisodia SS, Bhatnagar M. Hepatoprotective activity of Eugenia jambolana Lam.in carbon tetrachloride treated rats. Indian journal of Pharmacology. 2009Feb;41(1):23-7.
Ahmad Ghorbani, Hassan Rakhshandeh et al. Potentiating Effects of Lactuca sativa on Pentobarbital-Induced Sleep. Iranian Journal of Pharmaceutical Research. 2013;12(2):401-6.
Davidson C.S. — Guidelines for detection of hepatotoxicty due to drugs and chemical. USA: NIH publication, U.S. Department of Health and Education and Welfare NIH. 1979.
Koul IB, Kapil A. Effect of diterpenes from andrographispaniculata on antioxidant defense system and lipid peroxidation. Indian Journal of Pharmacology. 1994;26;296 – 300.
Rastogi R, Saksena S, Garg NK, Kapoor NK, Agarwal DP, Dhawan BN. Picroliv protects against alcohol-induced chronic hepatotoxicity in rats; PlantaMedica Journal. 1996June;62(3):283-5.
Stanca MH, Nagy A, Toaya M, Vlad L. Hepatoprotective effects of orally administered melatonin and tinosporacordifolia in experimental jaundice. Chirurgia (Bucur). 2011Mar-Apr;106(2):205-10.
Chagoya de Sa¡nchez V, Herna¡ndez-Muaoz R, Ya¡aez L, Vidrio S, Daaz-Muaoz M. Possible mechanism of adenosine protection in carbon tetrachloride acute hepatotoxicity. Role of adenosine by-products and glutathione peroxidase. Journal of Biochemical Toxicology. 1995Feb;10(1):41-50.
Recnagel RO. Carbon tetrachloride hepatotoxicity status and future prospects.Pharmacol Sci 1983;4:129-31.23.
Okuno H, Hazama H, Muraze T, Shiozaki Y, Sameshima Y. Drug metabolizing activity in rats with chronic liver injury induced by carbon tetrachloride: Relationship with the content of hydroxyproline in the liver. Jpn J Pharmacol 1986;41:363-71.
Paul F. Kantor, Arnaud Lucien, Raymond Kozak, Gary D. Lopaschuk. The Antianginal Drug Trimetazidine Shifts Cardiac Energy Metabolism From Fatty Acid Oxidation to Glucose Oxidation by Inhibiting Mitochondrial Long-Chain 3-Ketoacyl Coenzyme A Thiolase. Circulation Research Journal. 2000;86:580-8.
Ferhan Girgin, Onderkaraoglu, Muhan Erkus, Sevgi Tuzun. Effects of Trimetazidine on oxidant/antioxidant status in trinitrobenzenesulfonic acid induced chronic colitis. Journal of toxicology and environmental health,part A. 2000;59(8):641-52.
Michael T. Piel, J. Antonio Aldrete and George Jones. Influence of enzyme induction on the sleeping time of rats. Canadian Journal of Anesthesia. 1969Nov;16(6): 538-46.
Shah Shantilal J. editor, Antia FP, Naik SR. Liver Function Tests.In:A.P.I. text book of medicine. 4th edition. Bombay: Association of physicians of India; 1988: 633-4.
Sisodia SS, Bhatnagar M. Hepatoprotective activity of Eugenia Jambolana Lam. In carbon tetrachloride treated rats. Indian journal of Pharmacology. 2009Feb;41(1):23-7.
Chauhan BL, Mohan AR, Kulkarni Rd, Mitra SK. Bioassay for evaluation of the hepatoprotective effect of liv.52®, a polyherbal formulation, on ethanol metabolism in chronic alcohol - exposed rats. Indian Journal of Pharmacology. 1994;26: 117 – 20.
Shivani Pandey, Gujrati VR, Shanker K, Singh N and Dhawan KN. Hepatoprotective effect of Liv.52® Against CCl4-induced Lipid Peroxidation in Liver of Rats. Indian Journal of Experimental Biology. 1994 Sep;32:674-5.